India will have 5 more vaccines in the battle against Corona
The country is now in a mood to fight a decisive battle against the corona virus. India is expecting more than 2 billion vaccine supplements to be available in the country against the Corona virus by December this year. Although the vaccine campaign is currently underway in the country, but in addition to the serum Covishield and Bharat Biotech’s Covixin, more vaccines will be available in the coming years, which is currently underway. The government has presented a possible list of 8 vaccines, including Covishield, Covaxin and Sputnik-V (available from next week) and is undergoing vaccination in the country. V.K. According to Paul, 216 million doses of the vaccine are expected to be produced from August to December, of which 75 million doses of covisheal and 55 million doses of covaxine will be included. In addition, Biological E will provide 30 crore doses, Zayeds Cadila 5 crore, Serum Institute of India 200 million doses of Novavax and Bharat Biotech 10 million doses of its nasal vaccine, while Genova will provide 6 crore doses and Sputnik will provide 15.6 million doses.
NITI Aayog member VK Paul said that the Russian vaccine Sputnik-V will be available in the Indian markets next week. In addition to these three vaccines in the coming time, out of the five vaccines that are expected to be ready, four of the vaccines are made in India.
Biological E Subunit Vaccine: This is a subunit vaccine that is in the third phase of testing. This vaccine has been found to be safe in Phase I and Phase II trials. The government is very hopeful about this vaccine. The Center expects to receive 30 crore doses of this vaccine between August and December, provided it is allowed.
Zydes Cadila DNA Vaccine: The Zydes Cadila vaccine is in its Phase III trial and the company will soon apply for its license in India. It is a vaccine with three doses. The government hopes to get 50 million doses of the Zydes Cadila vaccine by December.
Novavax or Covavax: Serum Institute of India, the maker of Kovishield, will produce this vaccine in India. This vaccine has been developed by the American company Novavax.
Bharat Biotech’s Nasal Vaccine:
Bharat Biotech is working on nasal vaccine. This vaccine will be a single dose and will be needle-free, which is being developed by India Biotech. Currently, the first and second phases of this vaccine are undergoing trials. VK Paul said that the company has started functioning and data has also come from the company.
Genova mRNA vaccine: Genova Biopharmaceuticals Company of Pune is developing this messenger RNA vaccine (double-strand vaccine).
